This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

469 * Wed, 8/4/2010, 8:30 AM - 10:20 AM CC-216 (West)
Topics in Clinical Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Richard Caplan, AstraZeneca
8:35 AM The Case for Embedding a Detailed Statistical Analysis Plan in Clinical Trial Protocols — Chris Assaid, Merck Research Laboratories ; Keaven M. Anderson, Merck Research Laboratories
8:50 AM The Benefit of Stratified Clinical Trials Revisited Jitendra Ganju, Amgen Inc. ; Kefei Zhou, Amgen Inc.
9:05 AM Application of Methods for Assessing Risk-Benefit in Clinical Trials Menghui Chen, Merck & Co., Inc. ; Shailaja Suryawanshi, Merck & Co., Inc.
9:20 AM Assessing Treatment Effect in Clinical Trials with Dichotomous Endpoints Gang Jia, Merck & Co., Inc.
9:35 AM A 'Paradox' in the Use of an ANCOVA Model in Determination of Treatment Effect in Clinical Trials Chi-Hse Teng, Amylin Pharmaceuticals ; Larry Z. Shen, Amylin Pharmaceuticals ; Ping Yan, Amylin Pharmaceuticals
9:50 AM Benefit Risk Assessment Incorporating Time Component Paulette Ceesay, Merck & Co., Inc. ; Richard Entsuah, Merck & Co., Inc.
10:05 AM Floor Discussion

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.